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In the recent years, it has been of great interest to study the binding mechanism between the innate and adaptive immune
responses as interrelated processes for the development of multiple autoimmune diseases. Infection has been a well-known trigger
of autoimmunity and trauma has been related as well too. Cryptogenic antigens release, recognition of pathogenic structure, and
metabolicchangesgeneratedbybothstimulibeginaninﬂammatoryprocesswhichinturnactivatestheimmunesystemamplifying
T and B cell responses. The development of relapsing polychondritis after trauma may have a direct association with these events
and in turn probably trigger autoimmune phenomena.
1.Introduction
Proteins that are hidden in the tissues and by diﬀerent
events such as trauma begin to be recognized and attacked
by immune system are called cryptogenic antigens, so it
starts a process initially with innate and later with acquired
immunity mechanisms. An example of this condition is the
sympathetic ophthalmia (SO) where breaching of systemic
ocular barriers compromises the relative immune privilege
of the eye and causes sensitization to previously sequestered
uveoretinal antigens [1]. A similar mechanism is observed
in relapsing polychondritis (RP) started by local cartilage
trauma triggering an immune response against cartilage in
distant sites of the body and even in noncartilaginous tissues
[2].
2.Lessons Learnedof SO
This disease is precipitated by ocular trauma to one eye,
followed by destructive inﬂammation in the nontraumatized
or“sympathizing”eye[3].Itisthoughtthatantigensreleased
from the traumatized eye ﬁnd their way into the draining
lymph node and generate systemic immune response [4].
An accompanying infection may provide an adjuvant eﬀect,
although severe endophthalmitis, which quickly destroys
the injured eye and eliminates the source of antigen, may
actually lessen chances of developing the disease [5]. In
uveitic disease, it is believed that T cells are capable of
recognizing retinal antigens by microbial stimuli that may
be immunologically similar in structure to their cognate
retinal antigen (antigenic mimicry). Microbial components
alsointeractwithinnatepatternrecognitionreceptors(PRRs)
on antigen-presenting cells, generating “danger” signals that
are necessary to elicit inﬂammatory reactions. Following
exposure to an uveitogenic stimulus, circulating retinal
antigen-speciﬁc cells become activated and acquire eﬀectors
function [5]. In the above examples, it is postulated that
the retinal antigen recognition distance may be submitted
by local eﬀects, but it is obvious to assume that there is not
a similar type of tissue throughout the body. Therefore, we
cannot rule out that it can presented by a systemic eﬀect.2 Autoimmune Diseases
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Figure 1: Local cartilage trauma initiates an inﬂammatory process with or without infection as coadjuvant as well as activation of the innate
and adaptive immunity through induction of PAMPs, DAMPs, and cryptogenic antigens which are recognized by PRR (TLR, NLR) that
results in the production of IL-1B and IL-18. These interleukins amplify T and B cell responses and might serve as a crucial link into adaptive
immune responses. PRR, pattern recognition receptors; TLR, Toll-like receptors; NLR, NOD-like receptors; LTCD4, lymphocytes T CD4.
3.Local CartilageTraumaasa
Triggering Factor of RP
RP is a rare immune-mediated disease of unknown etiology
which is associated with inﬂammation in cartilaginous,
especially hyaline cartilage throughout the body.
Possible mechanisms involved are an autoimmune back-
ground and a trigger factor such as cancer, infection as
hepatitis C virus [6], or drugs (e.g., anti-TNF) [7]. In some
cases, recently reported cartilage trauma may be a trigger
of the disease in a susceptible person [8–10]. Puncture or
other type of trauma with or without presence of foreign
material in the cartilage and often associated with infection
could trigger an autoimmune disorder by exposing unusual
cartilage matrix protein antigens [11].
Also in this case like SO, probably the proteins that are
hidden in the tissues would be exposed by factors such as
trauma and begin to be recognized by the immune system
as foreign, triggering processes for their elimination initially
with innate and later with acquired immune mechanisms.
This process has not been clearly deﬁned; however, several
reported cases of RP have shown an association between
mechanical insult to cartilage and the development of more
local cartilage inﬂammation and even the involvement of
distant cartilaginous tissues [2].
One hypothesis comes out from these conditions and
interrelate innate immune response, and the activation of
the adaptive system may be mediated by PRR of the innate
immune cells such as Toll-like receptors (TLRs) and NOD-
(nucleotide-binding oligomerization domain-)like receptors
(NLRs). TLR family consists of 10 receptors that are divided
into membrane and endosomal localization and which
allow for recognition and response to pathogen-associated
molecular patterns (PAMPs) representing diverse microbial
products (lipopolysaccharide, ﬂagellin) of most pathogens
[12, 13]. This could explain the signiﬁcant role of infection
as a coadjuvant factor in OS and in our cases of RP. Infection
is a well-known contributing factor for the development of
autoimmunity [14, 15]. NLR family members are cytosolic
sensors of microbial components and danger signals such
as damage-associated molecular patterns (DAMPs) which
represent common metabolic consequences of infection and
inﬂammationreleasedduringthetissuedamageandcelllysis
and include high mobility group box 1 protein, alarmins,
heat shock proteins, and uric acid [16, 17].
These two ways of pattern recognition contribute to
making the link between innate and adaptive immune
response through the production and expression of IL-1B
and IL-18 generating an inﬂammatory response and acting
on lymphocytes in several pathways including upregulating
IL-2 receptor expression, which in turn prolongs survival
of T cells and increases B cell proliferation and production
of antibodies [18, 19]. IL-1B and IL-18 also play a crucial
role in driving the diﬀerentiation and ampliﬁcation of Th17
and Th1 cells, respectively [20, 21]. Thus, in general, these
interleukins amplify T and B cell responses and might serve
as a crucial link translating into adaptive immune responses
[18]. In the RP triggered by local trauma, the inﬂammatory
reaction may lead to the production of autoantibodies and
autoreactive T lymphocytes against cartilage structures (e.g.,
collagen type II) which in turn could develop chondritis at
other sites [22].Autoimmune Diseases 3
4. RP andSystemicAutoimmune Phenomena
It is well known and reported in the literature that about
30% of the patients with RP have additional autoimmune or
hematological diseases, most frequently systemic vasculitis,
rheumatoid arthritis, myelodysplastic syndromes, or sys-
temic lupus erythematous [23].
Recently, we reported a comparative analysis of 18
patients diagnosed with RP with or without tissue trauma (7
versus 11 patients, resp.) and evaluated the development of
the systemic autoimmune phenomena. The results showed
that the patients with previous local trauma lead to a greater
systemic autoimmune response shown by the development
of antinuclear antibodies, rheumatoid factor, antineutrophil
cytoplasmic antibodies, autoimmune thyroiditis, rheuma-
toid arthritis, and vasculitis [2]. Also included in this last
group, the description of an RP case induced by local carti-
lage trauma in the ankle with later development of central
nervous system compromise manifested as a hypertrophic
pachymeningitis, PR3 ANCAs-positive vaculitis outside of
thecompleteclinicalexpressionofaWegener’sgranulomato-
sis with request for aggressive treatment with cyclophos-
phamide and rituximab given severity of the condition and
poor initial response to treatment [24].
Figure 1 outlines the hypothetic steps in the pathogenesis
of autoimmunity in patients with local cartilage trauma and
development of RP.
5. Conclusions
Local cartilage trauma with or without infection triggers an
immune processes directed against cryptogenic antigens that
conduce to inﬂammation of cartilage both local and later in
other sites of the body. By diverse mechanisms which may
be implicated by PRR such as TLR and NLR, a systemic
autoimmune phenomena is induced. The presentation of RP
afterlocalcartilagetraumamayinﬂuencethepresenceofthis
systemic autoimmunity.
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